https://gloucestershiredaily.co.uk/tags/teplizumab/Recent content in teplizumab on Gloucestershire DailyHugo -- gohugo.ioen-usTue, 23 Jun 2026 05:27:27 +0000https://gloucestershiredaily.co.uk/diabetes-breakthrough-nhs-approves-therapy-that-delays-type-1-diabetes-onset-by-three-years/Tue, 23 Jun 2026 05:27:27 +0000https://gloucestershiredaily.co.uk/diabetes-breakthrough-nhs-approves-therapy-that-delays-type-1-diabetes-onset-by-three-years/A groundbreaking therapy capable of postponing the onset of type 1 diabetes for up to three years is set to be made available on the NHS, heralding a new era in diabetes care. The National Institute for Health and Care Excellence (NICE) has approved teplizumab—also known as Tzield and developed by Sanofi—as the first treatment that directly targets the immune system’s attack on insulin-producing cells. Teplizumab is authorized for use in children aged eight and older as well as adults diagnosed in the early, pre-symptomatic stages of type 1 diabetes.